ACLARIS THERAPEUTICS INC
ACRS · NASDAQ
Updated at 2026-10-15 04:54:16
- Today's High
- $3.47
- Today’s Low
- $3.34
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $3.38
- Previous Close
- $3.38
- Volume
- 2.58M
- Market Cap
- $529.91M
- P/E Ratio
- --
- EPS
- $-0.58
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Pharmaceuticals
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 701 LEE ROAD, WAYNE, PA, UNITED STATES, 19087
- Country
- US
- Listing Date
- 2015-10-07
- Fiscal Year End
- December
- Shares Outstanding
- 139.66M
- CIK
- 0001557746
- Website
- www.aclaristx.com
Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a line of novel small molecule therapeutics to address the needs of patients with immuno-inflammatory diseases. The company is headquartered in Wayne, Pennsylvania.
Financial Metrics
Revenue
2026-06-30
$1.62M
2026-03-31
$1.99M
2025-12-31
$1.29M
2025-09-30
$3.29M
Operating Expenses
2026-06-30
$25.63M
2026-03-31
$23.79M
2025-12-31
$24.83M
2025-09-30
$19.91M
Net Income
2026-06-30
-$21.5M
2026-03-31
-$19.82M
2025-12-31
-$19.79M
2025-09-30
-$14.61M
Net Profit Margin
2026-06-30
-1.32K%
2026-03-31
-993.18%
2025-12-31
-1.52K%
2025-09-30
-442.98%
Earnings Per Share
2026-06-30
$-0.15
2026-03-31
$-0.15
2025-12-31
$-0.16
2025-09-30
$-0.12
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$21.39M
2026-03-31
-$19.72M
2025-12-31
-$19.69M
2025-09-30
-$14.5M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $1.62M | $1.99M | $1.29M | $3.29M |
| Operating Expenses | $25.63M | $23.79M | $24.83M | $19.91M |
| Net Income | -$21.5M | -$19.82M | -$19.79M | -$14.61M |
| Net Profit Margin | -1.32K% | -993.18% | -1.52K% | -442.98% |
| Earnings Per Share | $-0.15 | $-0.15 | $-0.16 | $-0.12 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$21.39M | -$19.72M | -$19.69M | -$14.5M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.